China NMPA Product Recall - Werewolf Coblation System (plasma surgical equipment)

On July 18, 2022, ArthroCare Corporation, the manufacturer of the Werewolf Coblation System plasma surgical device, initiated a voluntary Class III recall. This significant regulatory action was publicly reported by Smith & Nephew Medical Products International Trading (Shanghai) Co., Ltd. The core issue identified involved manufacturing errors where an incorrect expiration date was printed on the device's surgical blades. This critical labeling inaccuracy renders the plasma surgical device unusable, posing a direct concern for operational effectiveness in medical procedures. The recall is being overseen by the National Medical Products Administration (NMPA) of China, which classified it as a Class III event. A Class III recall typically indicates a situation where use of or exposure to a violative product is not likely to cause adverse health consequences. The required action from ArthroCare Corporation is the immediate voluntary recall of all affected models and batches of the Werewolf Coblation System. Details regarding the specific products impacted are contained within a 'Medical Device Recall Event Report Form,' though the full contents were not provided. This incident underscores the stringent quality control and regulatory compliance expected from medical device manufacturers to ensure product integrity and patient safety under the NMPA's regulatory framework.